EXCLUSIVE: The Love List is back this Valentine’s Day with another round of picks for the 12 best unproduced, romance-centered screenplays and pilots of the year. The list was read and curated by a ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Zoe Vanderweide Zoe Vanderweide is a writer focused on style and accessories.

David Lynch‘s unproduced scripts for Unrecorded Night, a miniseries he shopped around in recent years, may see the light of day. The late filmmaker’s daughter, Jennifer, wrote on Reddit that she and ...

TV and home video editor Ty Pendlebury joined CNET Australia in 2006, and moved to New York City to be a part of CNET in 2011. He tests, reviews and writes about the latest TVs and audio equipment.

If you're a homeowner, you could be sitting on a lot of cash. A home equity line of credit (HELOC) lets you tap into your home's value with a revolving line of credit for renovations, college tuition ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The Trump administration announced that the company, a pharmacy benefit manager, had agreed to make significant changes to its practices. By Rebecca Robbins and Reed Abelson The reporters have ...

The last weekend of February is a quiet one, with popular streamers like Netflix and HBO Max waiting until next month to release their next biggest movies. That’s not the case with Hulu and Prime ...

Streaming subscribers are going to have a busy weekend ahead of them, because there are some great new shows to watch. Netflix has debuted Bridgerton season 4, part 2, which will wrap up most of this ...

Vanessa is a lead writer at CNET, reviewing and writing about the latest smartwatches and fitness trackers. She joined the brand first as an on-camera reporter for CNET's Spanish-language site, then ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...